• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Study of the tumor microenvironment during progression and acquisition of treatment resistance of renal cell carcinoma

Research Project

Project/Area Number 16K08657
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Human pathology
Research InstitutionKeio University

Principal Investigator

Mikami Shuji  慶應義塾大学, 医学部(信濃町), 講師 (20338180)

Co-Investigator(Kenkyū-buntansha) 小坂 威雄  慶應義塾大学, 医学部(信濃町), 講師 (30445407)
水野 隆一  慶應義塾大学, 医学部(信濃町), 講師 (60383824)
Project Period (FY) 2016-04-01 – 2019-03-31
Project Status Completed (Fiscal Year 2018)
Budget Amount *help
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2018: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2017: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2016: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Keywords腎細胞癌 / 微小環境 / プレシージョンメディスン / PD-1 / PD-L1 / VASH1 / 微小血管密度 / 腫瘍免疫 / 免疫チェックポイント阻害剤 / 分子標的治療 / コンパニオン診断 / VEGF-TKI / スニチニブ / ソラフェニブ / 免疫 / 耐性 / 血管新生 / 薬剤耐性
Outline of Final Research Achievements

VEGF-TKIs have become the first-line drugs for the treatment of metastatic and unresectable renal cell carcinoma. However, most cases become resistant to the treatment about 1 year after the initiation of the treatment. Therefore, elucidation of the molecular mechanism of the treatment resistance is important for the development of effective treatment. In this study, we focused on tumor micro-environment to investigate the molecular mechanism of the progression and acquisition of treatment resistance. As a result, it was found that expression of VASH1, a regulator of angiogenesis, in endothelial cells and PD-1/PD-L1 expression in tumor infiltrating immune cells were involved in resistance to VEGF-TKIs. This study suggested that targeting these molecules might be effective treatment for VEGF-TKI-resistant renal cell carcinoma.

Academic Significance and Societal Importance of the Research Achievements

進行性腎細胞癌の第一選択はVEGF-TKI阻害剤であるが、治療開始後約1年で大部分の症例が治療抵抗性になる。そのため、薬剤耐性の分子機構の解明が腎細胞癌の根治には重要である。本研究課題では、病理医と泌尿器科医が共同で腎細胞癌の臨床所見、病理学的所見に基づき、VEGF-TKI耐性に関与する腎細胞癌のがん微小環境を系統的に解析した。その結果、血管内皮細胞における血管制御因子VASH1発現および免疫担当細胞におけるPD-1/PD-L1発現がVEGF-TKI治療耐性に関与していることが判明したため、これらの分子を標的とした治療がVEGF-TKI抵抗性腎細胞癌の効果的な治療につながると考えられる。

Report

(4 results)
  • 2018 Annual Research Report   Final Research Report ( PDF )
  • 2017 Research-status Report
  • 2016 Research-status Report
  • Research Products

    (33 results)

All 2019 2018 2017 2016

All Journal Article (14 results) (of which Int'l Joint Research: 3 results,  Peer Reviewed: 14 results,  Open Access: 12 results,  Acknowledgement Compliant: 2 results) Presentation (12 results) (of which Invited: 3 results) Book (7 results)

  • [Journal Article] Clinical significance of PD-1 and PD-L1 expression in the tumor microenvironment of clear cell renal cell carcinoma.2019

    • Author(s)
      Mikami S, Mizuno R, Kondo T, Shinohara N, Nonomura N, Ozono S, Eto M, Tatsugami K, Takayama T, Matsuyama H, Kishida T, Oya M
    • Journal Title

      Cancer Sci

      Volume: 印刷中 Issue: 6 Pages: 1820-1828

    • DOI

      10.1111/cas.14019

    • Related Report
      2018 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Sulfasalazine could modulate the CD 44v9‐xCT system and enhance cisplatin‐induced cytotoxic effects in metastatic bladder cancer2019

    • Author(s)
      Ogihara Koichiro、Kikuchi Eiji、Okazaki Shogo、Hagiwara Masayuki、Takeda Toshikazu、Matsumoto Kazuhiro、Kosaka Takeo、Mikami Shuji、Saya Hideyuki、Oya Mototsugu
    • Journal Title

      Cancer Science

      Volume: 110 Issue: 4 Pages: 1431-1441

    • DOI

      10.1111/cas.13960

    • Related Report
      2018 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Impact of inflammatory marker levels one month after the first-line targeted therapy initiation on progression-free survival prediction in patients with metastatic clear cell renal cell carcinoma.2019

    • Author(s)
      Ito K, Masunaga A, Tanaka N, Mizuno R, Shirotake S, Yasumizu Y, Ito Y, Miyazaki Y, Hagiwara M, Kanao K, Mikami S, Momma T, Masuda T, Nakagawa K, Oyama M, Asano T, Oya M.
    • Journal Title

      Jpn J Clin Oncol

      Volume: 49(1) Issue: 1 Pages: 69-76

    • DOI

      10.1093/jjco/hyy154

    • Related Report
      2018 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Evaluation of prostate-specific antigen density in the diagnosis of prostate cancer combined with magnetic resonance imaging before biopsy in men aged 70 years and older with elevated PSA.2018

    • Author(s)
      Yanai Y, Kosaka T, Hongo H, Matsumoto K, Shinojima T, Kikuchi E, Miyajima A, Mizuno R, Mikami S, Jinzaki M, Oya M.
    • Journal Title

      Mol Clin Oncol.

      Volume: 9 Pages: 656-660

    • DOI

      10.3892/mco.2018.1725

    • Related Report
      2018 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Single-cell RNA-seq analysis reveals the platinum resistance gene COX7B and the surrogate marker CD632018

    • Author(s)
      Tanaka Nobuyuki、Katayama Shintaro、Reddy Aparna、Nishimura Kaneyasu、Niwa Naoya、Hongo Hiroshi、Ogihara Koichiro、Kosaka Takeo、Mizuno Ryuichi、Kikuchi Eiji、Mikami Shuji、Miyakawa Ayako、Arenas Ernest、Kere Juha、Oya Mototsugu、Uhl?n Per
    • Journal Title

      Cancer Medicine

      Volume: 7 Issue: 12 Pages: 6193-6204

    • DOI

      10.1002/cam4.1828

    • Related Report
      2018 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Variant isoforms of CD44 involves acquisition of chemoresistance to cisplatin and has potential as a novel indicator for identifying a cisplatin-resistant population in urothelial cancer2018

    • Author(s)
      Hagiwara Masayuki, Kikuchi Eiji, Tanaka Nobuyuki, Kosaka Takeo, Mikami Shuji, Saya Hideyuki, Oya Mototsugu
    • Journal Title

      BMC Cancer

      Volume: 18 Issue: 1

    • DOI

      10.1186/s12885-018-3988-3

    • Related Report
      2017 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Vasohibin-1 as a novel microenvironmental biomarker for patient risk reclassification in low-risk prostate cancer2018

    • Author(s)
      Kobayashi Hiroaki, Kosaka Takeo, Mikami Shuji, Miyazaki Yasumasa, Matsumoto Kazuhiro, Kikuchi Eiji, Miyajima Akira, Kameyama Kaori, Sato Yasufumi, Oya Mototsugu
    • Journal Title

      Oncotarget

      Volume: 9 Issue: 12 Pages: 10203-10210

    • DOI

      10.18632/oncotarget.23011

    • Related Report
      2017 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] The Conditional Survival with Time of Intravesical Recurrence of Upper Tract Urothelial Carcinoma2017

    • Author(s)
      Shigeta Keisuke, Kikuchi Eiji, Hagiwara Masayuki, Ando Toshiyuki, Mizuno Ryuichi, Abe Takayuki, Mikami Shuji, Miyajima Akira, Nakagawa Ken, Oya Mototsugu
    • Journal Title

      Journal of Urology

      Volume: - Issue: 6 Pages: 1278-1285

    • DOI

      10.1016/j.juro.2017.06.073

    • Related Report
      2017 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Clinicopathological study of 5 cases of renal cell carcinoma with t(6;11)(p21;q12).2017

    • Author(s)
      Kuroda N, Yorita K, Sasaki N, Ishihara A, Matsuura K, Daa T, Mori S, Sasaki A, Mikami S, Shigematsu K, Nagashima Y.
    • Journal Title

      Pol J Pathol.

      Volume: 68(1) Pages: 66-72

    • DOI

      10.5114/pjp.2017.67617

    • Related Report
      2017 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Increased vasohibin-1 expression is associated with metastasis and poor prognosis of renal cell carcinoma patients.2017

    • Author(s)
      Mikami S, Oya M, Kosaka T, Mizuno R, Miyazaki Y, Sato Y, Okada Y.
    • Journal Title

      Lab Invest.

      Volume: - Issue: 7 Pages: 854-862

    • DOI

      10.1038/labinvest.2017.26

    • Related Report
      2017 Research-status Report 2016 Research-status Report
    • Peer Reviewed / Open Access / Acknowledgement Compliant
  • [Journal Article] Diagnosis of Renal Angiomyolipomas: Classic, Fat-Poor, and Epithelioid Types.2017

    • Author(s)
      Jinzaki M, Silverman SG, Akita H, Mikami S, Oya M.
    • Journal Title

      Semin Ultrasound CT MR.

      Volume: 38 Issue: 1 Pages: 37-46

    • DOI

      10.1053/j.sult.2016.11.001

    • Related Report
      2016 Research-status Report
    • Peer Reviewed / Int'l Joint Research
  • [Journal Article] Endoscopic morphologic features of ulcerative colitis-associated dysplasia classified according to the SCENIC consensus statement2016

    • Author(s)
      Sugimoto S, Naganuma M, Iwao Y, Matsuoka K, Shimoda M, Mikami S, Mizuno S, Nakazato Y, Nanki K, Inoue N, Ogata H, Kanai T.
    • Journal Title

      Gastrointest Endosc.

      Volume: 85(3) Issue: 3 Pages: 639-646

    • DOI

      10.1016/j.gie.2016.11.013

    • Related Report
      2016 Research-status Report
    • Peer Reviewed
  • [Journal Article] Prognostic value of neutrophil-to-lymphocyte ratio in patients with metastatic renal cell carcinoma treated with first-line and subsequent second-line targeted therapy: A proposal of the modified-IMDC risk model.2016

    • Author(s)
      Tanaka N, Mizuno R, Yasumizu Y, Ito K, Shirotake S, Masunaga A, Ito Y, Miyazaki Y, Hagiwara M, Kanao K, Mikami S, Nakagawa K, Momma T, Masuda T, Asano T, Oyama M, Oya M
    • Journal Title

      Urol Oncol

      Volume: 35(2) Issue: 2 Pages: 19-39

    • DOI

      10.1016/j.urolonc.2016.10.001

    • Related Report
      2016 Research-status Report
    • Peer Reviewed / Open Access / Acknowledgement Compliant
  • [Journal Article] Acquired platinum resistance involves epithelial to mesenchymal transition through ubiquitin ligase FBXO32 dysregulation.2016

    • Author(s)
      Tanaka N, Kosaka T, Miyazaki Y, Mikami S, Niwa N, Otsuka Y, Minamishima YA, Mizuno R, Kikuchi E, Miyajima A, Sabe H, Okada Y, Uhlen P, Suematsu M, Oya M.
    • Journal Title

      JCI Insight

      Volume: 1

    • Related Report
      2016 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Presentation] 転移性腎細胞癌に対するニボルマブの効果予測因子の検討2018

    • Author(s)
      高松 公晴, 水野 隆一, 田中 伸之, 武田 利和, 森田 伸也, 松本 一宏, 小坂 威雄, 篠島 利明, 菊地 栄次, 浅沼 宏, 三上 修治, 大家 基嗣
    • Organizer
      第56回日本癌治療学会学術集会
    • Related Report
      2018 Annual Research Report
  • [Presentation] 上部尿路上皮癌におけるPD-1発現と喫煙の既往歴の関連2018

    • Author(s)
      案納 忠譜, 菊地 栄次, 荻原 広一郎, 早川 望, 松本 一宏, 三上 修治, 大家 基嗣
    • Organizer
      第56回日本癌治療学会学術集会
    • Related Report
      2018 Annual Research Report
  • [Presentation] 上部尿路上皮癌におけるPD-1発現と喫煙の既往歴の関連2018

    • Author(s)
      早川 望, 菊地 栄次, 三上 修治, 大家 基嗣
    • Organizer
      第106回日本泌尿器科学会総会
    • Related Report
      2018 Annual Research Report
  • [Presentation] 分子標的薬1次治療が短期間で中止された進行性腎癌症例の検討2018

    • Author(s)
      伊藤 敬一, 升永 綾子, 田中 伸之, 城武 卓, 水野 隆一, 安水 洋太, 伊藤 祐二郎, 宮崎 保匡, 萩原 正幸, 金尾 健人, 三上 修治, 門間 哲雄, 中川 健, 増田 毅, 小山 政史, 浅野 友彦, 大家 基嗣
    • Organizer
      第106回日本泌尿器科学会総会
    • Related Report
      2018 Annual Research Report
  • [Presentation] 腎尿管全摘除術が施行されたTa-3N0M0腎盂尿管癌におけるconditional survival analysis法を用いた予後解析2018

    • Author(s)
      茂田 啓介, 菊地 栄次, 萩原 正幸, 水野 隆一, 阿部 貴行, 三上 修治, 中川 健, 宮嶋 哲, 大家 元嗣
    • Organizer
      106回日本泌尿器科学会総会
    • Related Report
      2018 Annual Research Report
  • [Presentation] 腎腫瘍の非典型例 WHO分類(2016年)に基づいた非淡明細胞型腎細胞癌の病理診断2017

    • Author(s)
      三上修治
    • Organizer
      第36回日本画像医学会
    • Place of Presentation
      ステーションコンファレンス東京(東京都・千代田区)
    • Year and Date
      2017-02-25
    • Related Report
      2016 Research-status Report
    • Invited
  • [Presentation] 前立腺癌における予後因子としてのバソヒビン2発現の検討2017

    • Author(s)
      宮崎 保匡, 小坂 威雄, 三上 修治, 安水 洋太, 田中 伸之, 菊地 栄次, 佐藤 靖史, 大家 基嗣
    • Organizer
      日本癌学会総会
    • Related Report
      2017 Research-status Report
  • [Presentation] BCG膀注療法を施行したT1筋層非浸潤性膀胱癌における新たな病理組織因子”Tumor budding"の臨床的意義2017

    • Author(s)
      菊地 栄次, 福本 桂資郎, 三上 修治, 宮嶋 哲, 大家 基嗣
    • Organizer
      日本泌尿器外科学会
    • Related Report
      2017 Research-status Report
  • [Presentation] 免疫チェックポイント阻害剤の現状と今後の展望2017

    • Author(s)
      水野 隆一, 三上 修治, 大家 基嗣
    • Organizer
      日本泌尿器科学会総会
    • Related Report
      2017 Research-status Report
    • Invited
  • [Presentation] 腎腫瘍の非典型例 WHO分類(2016年)に基づいた非淡明細胞型腎細胞癌の病理診断2017

    • Author(s)
      三上 修治
    • Organizer
      日本画像医学会
    • Related Report
      2017 Research-status Report
    • Invited
  • [Presentation] 上部尿路上皮癌におけるPD-1発現の臨床的検討2017

    • Author(s)
      弓削 和之, 菊地 栄次, 早川 望, 福本 桂資郎, 小坂 威雄, 三上 修治, 宮嶋 哲, 飯沼 誠一, 大家 基嗣
    • Organizer
      日本泌尿器科学会総会
    • Related Report
      2017 Research-status Report
  • [Presentation] 前立腺がんの病理に基づく治療戦略 低リスク前立腺癌におけるがん微小環境マーカーとしてのVasohibin-1発現の臨床的意義2016

    • Author(s)
      小林 裕章, 小坂 威雄, 三上 修治, 宮崎 保匡, 松本 一宏, 菊地 栄次, 宮嶋 哲, 亀山 香織, 佐藤 靖史, 大家 基嗣
    • Organizer
      第54回日本癌治療学会
    • Place of Presentation
      パシフィコ横浜(神奈川県・横浜市)
    • Year and Date
      2016-10-20
    • Related Report
      2016 Research-status Report
  • [Book] 病理組織の見方と鑑別診断「腎腫瘍」・「尿路腫瘍」2018

    • Author(s)
      三上 修治
    • Total Pages
      728
    • Publisher
      医歯薬出版
    • ISBN
      4263731859
    • Related Report
      2018 Annual Research Report
  • [Book] Renal Cell Carcinoma: Molecular Features and Treatment Updates2017

    • Author(s)
      Shuji Mikami, Naoto Kuroda, Yoji Nagashima
    • Total Pages
      381
    • Publisher
      Springer
    • ISBN
      9784431555315
    • Related Report
      2017 Research-status Report
  • [Book] 映像情報Medical 腎腫瘍はCT/MRIでここまで鑑別できる2017

    • Author(s)
      秋田 大宇, 陣崎 雅弘, 三上 修治, 大家 基嗣
    • Total Pages
      180
    • Publisher
      産業開発機構株式会社
    • ISBN
      9784860282851
    • Related Report
      2017 Research-status Report
  • [Book] 病理と臨床35巻10号【腎臓の腫瘍】 腎腫瘍WHO2016新分類2017

    • Author(s)
      三上 修治, 黒田直人, 長嶋洋治
    • Total Pages
      80
    • Publisher
      文光堂
    • Related Report
      2017 Research-status Report
  • [Book] 腎臓内科・泌尿器科 腎細胞がんの核異型度評価の変遷2017

    • Author(s)
      三上 修治, 黒田直人, 長嶋洋治
    • Total Pages
      334
    • Publisher
      科学評論社
    • Related Report
      2017 Research-status Report
  • [Book] 映像情報Medical 腎腫瘍のWHO分類の改定の要点と病理診断のポイント2017

    • Author(s)
      三上 修治
    • Total Pages
      180
    • Publisher
      産業開発機構株式会社
    • ISBN
      9784860282851
    • Related Report
      2017 Research-status Report
  • [Book] Renal Cell Carcinoma: Molecular Features and Treatment Updates2017

    • Author(s)
      Mikami S, Kuroda N, Nagashima Y
    • Total Pages
      381
    • Publisher
      Springer
    • Related Report
      2016 Research-status Report

URL: 

Published: 2016-04-21   Modified: 2020-03-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi